Product NewsThe German National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG Investigate Responsiveness to Checkpoint Inhibitors in Melanoma
Product NewsPall ForteBio Acquires the Pioneer SPR Product Line from SensiQ Technologies to Expand Its Label-Free Interaction Analysis Portfolio
Expert InsightsWebinar Highlights: Advanced Molecular and Cellular Technologies for Better Monitoring of HIV+ Patients
Editorial ArticlePrescreening of Collagen Content in Archaeological Bone Samples at the University of Oxford